A mechanism-based understanding of bone cancer pain

Patrick W Mantyh, Dray, Belmonte, Devor

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Although bone cancer pain can be severe and is relatively common, as it frequently arises from metastases from breast, prostate and lung tumours, relatively little is known about the basic mechanisms that generate and maintain this chronic pain. To begin to define the mechanisms that give rise to bone cancer pain, we developed a mouse model using the intramedullary injection and containment of osteolytic sarcoma cells into the mouse femur. These tumour cells induced bone destruction as well as ongoing and movement evoked pain behaviours similar to that found in patients with bone cancer pain. In addition, there was a significant neurochemical reorganization of sensory neurons that innervate the tumour bearing bone as well as in the spinal cord segments that received sensory input from the cancerous bone. This reorganization generated a neurochemical signature of bone cancer pain that was different from that observed in mouse models of chronic neuropathic or inflammatory pain. These data suggest that there is an inflammatory, neuropathic and tumorigenic component to bone cancer pain. Therefore defining when and how these different components drive bone cancer pain may allow the development of more selective analgesic agents to treat this chronic pain state.

Original languageEnglish (US)
Pages (from-to)194-219
Number of pages26
JournalNovartis Foundation Symposium
Volume261
StatePublished - 2004
Externally publishedYes

Fingerprint

Bone Neoplasms
Bone and Bones
Chronic Pain
Pain
Neoplasms
Sensory Receptor Cells
Sarcoma
Femur
Analgesics
Cancer Pain
Prostate
Spinal Cord
Breast
Neoplasm Metastasis
Lung
Injections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A mechanism-based understanding of bone cancer pain. / Mantyh, Patrick W; Dray; Belmonte; Devor.

In: Novartis Foundation Symposium, Vol. 261, 2004, p. 194-219.

Research output: Contribution to journalArticle

Mantyh, Patrick W ; Dray ; Belmonte ; Devor. / A mechanism-based understanding of bone cancer pain. In: Novartis Foundation Symposium. 2004 ; Vol. 261. pp. 194-219.
@article{acdd20d869124b479c5903665c38885c,
title = "A mechanism-based understanding of bone cancer pain",
abstract = "Although bone cancer pain can be severe and is relatively common, as it frequently arises from metastases from breast, prostate and lung tumours, relatively little is known about the basic mechanisms that generate and maintain this chronic pain. To begin to define the mechanisms that give rise to bone cancer pain, we developed a mouse model using the intramedullary injection and containment of osteolytic sarcoma cells into the mouse femur. These tumour cells induced bone destruction as well as ongoing and movement evoked pain behaviours similar to that found in patients with bone cancer pain. In addition, there was a significant neurochemical reorganization of sensory neurons that innervate the tumour bearing bone as well as in the spinal cord segments that received sensory input from the cancerous bone. This reorganization generated a neurochemical signature of bone cancer pain that was different from that observed in mouse models of chronic neuropathic or inflammatory pain. These data suggest that there is an inflammatory, neuropathic and tumorigenic component to bone cancer pain. Therefore defining when and how these different components drive bone cancer pain may allow the development of more selective analgesic agents to treat this chronic pain state.",
author = "Mantyh, {Patrick W} and Dray and Belmonte and Devor",
year = "2004",
language = "English (US)",
volume = "261",
pages = "194--219",
journal = "Novartis Foundation Symposium",
issn = "1528-2511",
publisher = "Novartis Foundation",

}

TY - JOUR

T1 - A mechanism-based understanding of bone cancer pain

AU - Mantyh, Patrick W

AU - Dray,

AU - Belmonte,

AU - Devor,

PY - 2004

Y1 - 2004

N2 - Although bone cancer pain can be severe and is relatively common, as it frequently arises from metastases from breast, prostate and lung tumours, relatively little is known about the basic mechanisms that generate and maintain this chronic pain. To begin to define the mechanisms that give rise to bone cancer pain, we developed a mouse model using the intramedullary injection and containment of osteolytic sarcoma cells into the mouse femur. These tumour cells induced bone destruction as well as ongoing and movement evoked pain behaviours similar to that found in patients with bone cancer pain. In addition, there was a significant neurochemical reorganization of sensory neurons that innervate the tumour bearing bone as well as in the spinal cord segments that received sensory input from the cancerous bone. This reorganization generated a neurochemical signature of bone cancer pain that was different from that observed in mouse models of chronic neuropathic or inflammatory pain. These data suggest that there is an inflammatory, neuropathic and tumorigenic component to bone cancer pain. Therefore defining when and how these different components drive bone cancer pain may allow the development of more selective analgesic agents to treat this chronic pain state.

AB - Although bone cancer pain can be severe and is relatively common, as it frequently arises from metastases from breast, prostate and lung tumours, relatively little is known about the basic mechanisms that generate and maintain this chronic pain. To begin to define the mechanisms that give rise to bone cancer pain, we developed a mouse model using the intramedullary injection and containment of osteolytic sarcoma cells into the mouse femur. These tumour cells induced bone destruction as well as ongoing and movement evoked pain behaviours similar to that found in patients with bone cancer pain. In addition, there was a significant neurochemical reorganization of sensory neurons that innervate the tumour bearing bone as well as in the spinal cord segments that received sensory input from the cancerous bone. This reorganization generated a neurochemical signature of bone cancer pain that was different from that observed in mouse models of chronic neuropathic or inflammatory pain. These data suggest that there is an inflammatory, neuropathic and tumorigenic component to bone cancer pain. Therefore defining when and how these different components drive bone cancer pain may allow the development of more selective analgesic agents to treat this chronic pain state.

UR - http://www.scopus.com/inward/record.url?scp=7444268906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444268906&partnerID=8YFLogxK

M3 - Article

C2 - 15469052

AN - SCOPUS:7444268906

VL - 261

SP - 194

EP - 219

JO - Novartis Foundation Symposium

JF - Novartis Foundation Symposium

SN - 1528-2511

ER -